Working… Menu

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00276575
Recruitment Status : Completed
First Posted : January 13, 2006
Last Update Posted : November 19, 2014
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Herbert Hurwitz, MD, Duke University